Candelaria Hernández, M., X. López Karpovitch, F. Javier Mijangos, E. Montaño, A. Lemus Carmona, S. Guzmán Vázquez, and H. Soto Molina. “Cost-Effectiveness of Azacitidine Compared With Low-Doses of Chemotherapy (LDC) in Myelodysplastic Syndrome (MDS)”. Global and Regional Health Technology Assessment, vol. 4, no. 1, May 2017, pp. 114-21, doi:10.33393/grhta.2017.385.